Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir-Reference-Cited by-同舟云学术

Host-targeted nitazoxanide has a high barrier to resistance but does not reduce the emergence or proliferation of oseltamivir-resistant influenza viruses in vitro or in vivo when used in combination with oseltamivir

Published:2020-08 Issue: Volume:180 Page:104851
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Tilmanis Danielle,Koszalka Paulina^ORCID,Barr Ian G.,Rossignol Jean-Francois,Mifsud Edin,Hurt Aeron C.

Funder

Australian Government Department of Health

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference45 articles.

1. Glycosylation of seasonal influenza vaccine hemagglutinins: implication for potency testing and immune processing;An;J. Virol.,2019

2. T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro;Baranovich;J. Virol.,2013

3. Status of direct-acting antiviral therapy for HCV infection and remaining challenges;Baumert;Gastroenterology,2019

4. Combination therapy with oseltamivir and favipiravir delays mortality but does not prevent oseltamivir resistance in immunodeficient mice infected with pandemic A(H1N1) influenza virus;Baz;Viruses,2018

5. Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial;Beigel;Lancet Infect. Dis.,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considerations when treating influenza infections with oseltamivir;Expert Opinion on Pharmacotherapy;2024-07-02

2. Nanozybiotics: Advancing Antimicrobial Strategies Through Biomimetic Mechanisms;Advanced Materials;2024-06-26

3. Natural products as potential lead compounds to develop new antiviral drugs over the past decade;European Journal of Medicinal Chemistry;2023-11

4. Molecular identification of neuraminidase gene mutations in influenza A/H1N1 and A/H3N2 isolates of Mazandaran province, north of Iran;Journal of Global Antimicrobial Resistance;2023-11

5. Can Nitazoxanide and/or other anti‐viral medications be a solution to long COVID? Case report with a brief literature review;Clinical Case Reports;2023-11